Search

everythinglearnresearchcommunity

for

Search:↓

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Scalp psoriasis in China mostly affects young adults, worsens with stress, and significantly impacts quality of life.

Aesthetic rehabilitation techniques can improve life quality and wellbeing for disabled patients.

COVID-19 may cause a common type of hair loss called telogen effluvium.

Hair loss is a symptom of long COVID and can be treated with a protein-rich diet.

COVID-19 may cause increased hair loss, but the exact reason is unclear and standard hair loss treatments are recommended.

Modern research supports traditional uses of Yarrow for hair loss and skin issues.

A compound from Aloe barbadensis Miller can help regrow hair better than minoxidil.

Onion and Aloe vera can help protect hair from damage caused by hair dyes.

Using 5% minoxidil foam twice daily can help regrow hair, especially in younger men aged 20-30.

Targeted testing for telogen effluvium patients can save healthcare costs.

Neutrophil extracellular traps slow down hair follicle healing after injury.

The conclusion is that fat tissue in the skin is a new finding in Frontal fibrosing alopecia and may contribute to hair follicle and muscle degeneration.

More research is needed to see if non-English speakers are also more interested in oral minoxidil.

Haplogroup X found in Altaian population supports Amerindian origin.

Raspberry ketone lacks sufficient human research to support health benefit claims and requires more rigorous studies to confirm its safety and effectiveness.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

COVID-19 can cause a type of hair loss that usually starts 3-6 months after the illness, and treatment includes stress reduction and hair care products like Minoxidil.

Finasteride effectively treats frontal hair loss with few side effects.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

Certain mouse strains develop a skin condition similar to a human hair loss disease due to genetic defects.

Different harmful mutations in the CDH3 gene cause HJMD, but symptoms vary among individuals.

Different Myc family proteins are located in various parts of the hair follicle and may affect stem cell behavior.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.